PCC reports stronger Q3 earnings and maintains 2026 outlook

Key highlights
  • Third-quarter revenue increased 7.3% to €241.0 million and EBITDA rose 25.1% to €30.7 million.
  • PCC expects 2026 revenue to grow 5%–10% to nearly €1 billion and EBITDA before one-off effects to exceed €100 million.
  • Trading & Services EBITDA increased 139.2% to €10.7 million in the third quarter.
  • PCC SE repaid its €10 million, 4.00% bullet bond at maturity on October 1, 2026.

Group performance

Third-quarter 2026 revenue rose 7.3% year on year to €241.0 million, while EBITDA increased 25.1% to €30.7 million. For the first nine months, revenue was €706.8 million, down 0.3%, and EBITDA reached €75.7 million, up 30.7%. Nine-month EBIT improved to a profit of €11.1 million from a loss of €4.8 million a year earlier. The third-quarter EBT loss narrowed to €2.6 million from €9.3 million.

Outlook and segments

PCC confirmed its positive full-year outlook. Its July forecast anticipates revenue growth of 5%–10% to nearly €1 billion, EBITDA before one-off effects above €100 million, and a return to positive EBIT. Surfactants & Derivatives revenue rose 9.2% to €69.6 million, although EBITDA declined 3.2% to €6.2 million. Polyols & Derivatives revenue increased 7.3% to €48.0 million. Chlorine & Derivatives revenue rose 3.5% to €44.5 million.

Trading & Services revenue grew 41.9% to €33.4 million and EBITDA rose 139.2% to €10.7 million. Logistics revenue increased 5.3% to €42.3 million, with EBITDA up 43.0% to €8.6 million. Silicon metal production remained temporarily shut down; PCC continued negotiations on a sustainable restart, with agreements expected by year-end.

Corporate actions

PCC SE and PCC Rokita SA signed an agreement to transfer the monochloroacetic acid business, including MCAA SE and PCC MCAA Sp. z o.o., to PCC Rokita SA. PCC SE also repaid its €10 million bullet bond at maturity on October 1, 2026; the bond carried a 4.00% annual coupon.

Source: PCC SE

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.

Related articles

16 October 2026
PCC SE contributes MCAA subsidiaries into PCC Rokita to consolidate chlorine & derivatives

MCAA subsidiaries valued at EUR 61.4m transferred via share swap; 4,027,312 new shares issued, raising the group's stake to 76.4% and integrating MCAA with chlorine production.

17 June 2026
PCC SE consolidates MCAA business into PCC Rokita SA

Share-swap would issue 4,251,619 new shares using a six‑month VWAP example (68.05 PLN), implying about €68m valuation; aims to centralise MCAA production and capture synergies.

23 January 2025
European Commission finds Poland's €23m aid to PCC MCAA compliant with EU rules

Two measures — a €16m direct grant and up to €7m tax exemption — supported an ultra‑pure monochloroacetic acid plant in Brzeg Dolny; Commission found them compatible under regional aid rules.

24 August 2026
PCC Rokita and PCC EXOL: new alkoxylates and specialty chemicals plant in Brzeg Dolny

New flexible plant in Brzeg Dolny to produce non‑ionic surfactants, polyether polyols and ethoxylated compounds; completion targeted by end‑2028; investment ~PLN 842m.

1 July 2026
EU Commission opens antidumping probe into Chinese polyether polyols after PCC Rokita complaint

Antidumping probe targets Chinese imports of polyether polyols; provisional tariffs possible within 7 months, final measures in up to 14 months.